D-dimer in the year 2000: Present data and new prospects;Il D-dimero nell'anno 2000: Dati attuali e nuove prospettive

Annali Italiani di Medicina Interna

Volumn 15, Issue 4, 2000, Pages 267-272

  Prisco, D ^a   Antonucci, E ^a   Marcucci, R ^a   Pepe, G ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

D DIMER; FIBRIN;

CARDIOVASCULAR RISK; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; LUNG EMBOLISM; PROGNOSIS; REVIEW; RISK FACTOR;

ALGORITHMS; BIOLOGICAL MARKERS; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEART DISEASES; HUMANS; PULMONARY EMBOLISM; RISK FACTORS; VENOUS THROMBOSIS;

EID: 0034492739     PISSN: 03939340     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Valutazione critica delle nuove metodiche per lo studio dei prodotti di degradazione della fibrina
2. Clinical application of fibrinolysis laboratory tests: A review
3. Quantitative plasma D-dimer levels among patients undergoing pulmonary angiography for suspected pulmonary embolism
4. D-dimer testing for suspected pulmonary embolism in outpatients
5. Deep-vein thrombosis
6. Plasma measurement of D-dimer as diagnostic aid in suspected x plasboembolism: An overview
7. Exclusion of deep venous thrombosis with D-dimer testing
8. Relationship between classical FDP test and D-dimer assayed both by latex agglutination and ELISA
9. Comparison of new rapid methods for D-dimer measurement to exclude deep vein thrombosis in symptomatic outpatients
10. Linee Guida per la diagnosi, la profilassi e la terapia del tromboembolismo venoso
11. Simplified pression ultrasound strategy for the diagnostic management of compatients with clinically suspected venous thrombosis
12. Non invasive diagnosis of venous thromboembolism in outpatients
13. D-dimer assays for exclusion of venous thromboembolism: Which test for which diagnostic strategy?
14. Value of assessment of pre-test probability of deep-vein thrombosis in clinical management
15. Application of a diagnostic clinical model for the management for hospitalized patients with suspected deep-vein thrombosis
16. Thrombosis in the emergency department: Use of a clinical diagnosis model to safely avoid the need of urgent radiological investigation
17. Use of fibrinogen and fibrin D-dimer in prediction of arterial thrombotic events
18. Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men
19. Fibrin D-dimer, tissue plasminogen activator inhibitor, and the risk of major ischaemic heart disease in the Caerphilly Study
20. Cross-linked fibrin degradation products, progression of peripheral arterial disease
21. Hemostatic factors as Predictors of ischemic heart disease and stroke in the Edinburgh Artery Study
22. Association of fibrinolytic parameters with early atherosclerosis. The ARIC Study: Atherosclerosis Risk in Communities Study
23. D-dimers in relation to the severity of arteriosclerosis in patients with stable angina pectoris after myocardial infarction
24. Fibrinolytic activation markers predict myocardial infarction in the elderly. The Cardiovascular Health Study
25. Thrombogenic factors and recurrent coronary events
26. Increased markers of thrombogenesis in chronic atrial fibrillation
27. Effects of warfarin therapy On plasma fibrinogen, von Willebrand factor and fibrin D-dimer in left ventricular dysfunction secondary to coronary artery disease with and without aneurysm
28. Fibrin D-dimer and β thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin
29. Increased intracardiovascular clotting in patients with chronic atrial fibrillation
30. Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation
31. Plasma fibrinogen and fibrin D-dimer in patients with atrial fibrillation: Effects of cardioversion to sinus rhythm
32. Electrophysiologic procedures and activation of the hemostatic system
33. Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation: Evidence for intermediate elevated levels of intravascular thrombogenesis
34. Prothrombotic state and elevated levels of plasminogen activator inhibitor-1 in mitral stenosis with and without atrial fibrillation
35. Relation of endothelium, thrombogenesis and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy
36. Prothrombotic factors, endothelial function and left ventricular hypertrophy in isolated systolic hypertension compared with systolic-diastolic hypertension